Ringens P J, van Haperen R, Vennegoor C, de Jong P T, van Duinen S G, Ruiter D J, van der Kamp A W
Department of Ophthalmology, Erasmus University Rotterdam, Eye Hospital, The Netherlands.
Graefes Arch Clin Exp Ophthalmol. 1989;227(3):287-90. doi: 10.1007/BF02172764.
Three monoclonal antibodies (MoAbs) prepared against cutaneous melanomas were tested against one group of 12 choroidal melanomas with indirect immunofluorescence in frozen sections. A fourth MoAb was tested in paraffin sections of a second group of 47 choroidal melanomas. One MoAb (NKI-M7) did not react with choroidal melanoma, even though it had a high sensitivity for cutaneous melanoma. A second MoAb (NKI-M6) showed a positive reaction with only 2/12 choroidal melanomas. The third MoAb (NKI/beteb) reacted with all choroidal melanomas, regardless of the cell type. MoAb NKI/C-3 was positive with 38/47 (81%) choroidal melanomas. We conclude that NKI/C-3 and NKI/beteb have a high sensitivity for both cutaneous and choroidal melanomas in frozen sections. Of these two antibodies NKI/beteb was the most specific for cutaneous naevi and melanomas.
针对皮肤黑色素瘤制备的三种单克隆抗体(MoAbs),采用间接免疫荧光法在冷冻切片中对一组12例脉络膜黑色素瘤进行检测。第四种MoAb在另一组47例脉络膜黑色素瘤的石蜡切片中进行检测。一种单克隆抗体(NKI-M7)对脉络膜黑色素瘤无反应,尽管它对皮肤黑色素瘤具有高敏感性。第二种单克隆抗体(NKI-M6)仅对2/12的脉络膜黑色素瘤呈阳性反应。第三种单克隆抗体(NKI/beteb)与所有脉络膜黑色素瘤发生反应,无论细胞类型如何。单克隆抗体NKI/C-3对38/47(81%)的脉络膜黑色素瘤呈阳性。我们得出结论,在冷冻切片中,NKI/C-3和NKI/beteb对皮肤和脉络膜黑色素瘤均具有高敏感性。在这两种抗体中,NKI/beteb对皮肤痣和黑色素瘤最为特异。